BridgeMD
Tests treatment safety and results for Fatigue Related to Cancer Treatment
Official title Evaluation of the Feasibility and Safety of ENCER for Cancer Treatment-Related Fatigue in Patients Receiving Chemotherapy or Radiotherapy
ClinicalTrials.gov ID: NCT07707648
What this study is testing
What is encer?
encer is an investigational medicine, being studied as a potential treatment for fatigue related to cancer treatment.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a feasibility, double blind, placebo-controlled clinical study designed to evaluate the effect of 'Encer' on Cancer treatment Related Fatigue. 'Encer' is a combination of 5 Homeopathic Medical Product (HMP).
- Phase 1: an early, usually small safety study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Subject's informed consent
- Either male or female
- Age 18 and above
- Diagnosed with cancer (any type of solid tumor)
- Patients planned for their initial treatment or a new regimen of chemotherapy, (at least 4 treatments planned within 12 weeks) a new regimen of...
You likely can't join if
- Unable to give informed consent
- Planned Radiotherapy for less than 15 fractions
- Chemotherapy anticipated for less than 12 weeks, or fewer than 4 treatments
- Life expectancy of less than 3 months
- Patient is a dependent of the sponsor, of the investigational team or his/her immediate family
- Pregnant or nursing women
See the full eligibility criteria
- Subject's informed consent
- Either male or female
- Age 18 and above
- Diagnosed with cancer (any type of solid tumor)
- Patients planned for their initial treatment or a new regimen of chemotherapy, (at least 4 treatments planned within 12 weeks) a new regimen of radiotherapy (at least 15 fractions planned)
- Able to interface with digital questionnaire sent to the patient electronically
- Willing to wear a smartwatch that will detect physiological measurements for the duration of the trial
- Not currently treated with homeopathic remedy (for at least one week prior to study treatment)
- Unable to give informed consent
- Planned Radiotherapy for less than 15 fractions
- Chemotherapy anticipated for less than 12 weeks, or fewer than 4 treatments
- Life expectancy of less than 3 months
- Patient is a dependent of the sponsor, of the investigational team or his/her immediate family
- Pregnant or nursing women
The study team makes the final eligibility decision.
Where it's taking place
- Tel Aviv, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tel Aviv, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.